Ketorolac in Palatoplasty
ConditionCleft Lip and Palate
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age6+
SponsorThe University of Texas Health Science Center, Houston
About this trial
The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively
Eligibility criteria
Qualifiers
None
Disqualifiers
Syndromic Cleft Palate patients
Previous palatoplasty
Major unrepaired cardiac malformation
History of GI complications (GI Bleed, Gastric Ulceration)
Trial design
Treatments tested in this trial
- Ketorolac
- Placebo
Treatment groups
74 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov